Role of central tachykinin peptides in cardiovascular regulation in rats.
The mechanisms of action of tachykinin peptides thought to be involved in central cardiovascular regulation were examined. Intracerebroventricular injections (i.c.v.) of tachykinin peptides caused dose-dependent increases in blood pressure and heart rate. The pressor responses to substance P (SP) (10 micrograms, i.c.v.) and neurokinin A (NKA) (10 micrograms, i.c.v.) were blocked by peripheral administration of pentolinium or phentolamine, and partially attenuated by adrenalectomy. In contrast, the only initial pressor response to the neurokinin B (NKB) analogue senktide (10 micrograms, i.c.v.) was blocked by pentolinium or phentolamine. The pressor response to senktide was inhibited by pretreatment with a vasopressin V1 receptor antagonist (d(CH2)5OMe(Tyr)AVP) (10 micrograms/kg, i.v.), and senktide (10 micrograms, i.c.v.) caused an increase in plasma vasopressin level. However, the vasopressin antagonist did not influence the SP- and NKA-induced pressor responses. These results suggest that central SP and NKA increase the blood pressure and heart rate via sympathetic nerve activity, whereas central NKB increases the blood pressure mainly via release of vasopressin from the hypothalamus.
Takano
Y
Y
Department of Pharmacology, Faculty of Pharmaceutical Sciences, School of Medicine, Fukuoka University, Japan.
Nagashima
A
A
Hagio
T
T
Tateishi
K
K
Kamiya
H
H
D000311:Adrenal Glands / Q000502:physiology; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D007276:Injections, Intraventricular; D008297:Male; D010446:Peptide Fragments / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D012504:Saralasin / Q000494:pharmacology; D013373:Substance P / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D013565:Sympatholytics / Q000494:pharmacology; D015320:Tachykinins / Q000502:physiology*; D014667:Vasopressins / Q000097:blood*
D010446:Peptide Fragments; D013565:Sympatholytics; D015320:Tachykinins; C054724:senktide; D014667:Vasopressins; D000804:Angiotensin II; D013373:Substance P; D012504:Saralasin